The Pfizer-BioNTech vaccine should protect from the new strain as it targets the spike protein. When more mutations occur, the vaccine may need to be modified.

Pfizer-BioNTech's COVID-19 vaccine, which was once hailed as a lifesaver, has been found to have subtle but serious side ...

BioNTech SE and Pfizer (PFE) recently received a positive recommendation from the European Medicines Agency for marketing ...

An expert panel of the EU drug regulator, the European Medicines Agency (EMA) on Friday recommended marketing authorizations ...

Data indicate that the LP.8.1-adapted COVID-19 vaccine confers improved immune response against currently dominant and emerging sublineages - including the XFG and NB.1.8.1 variants1 - compared to ...

Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.

Third dose of Pfizer-BioNTech: Are you eligible? DHA clarifies eligible categories for third dose of the COVID-19 vaccine Last updated: September 02, 2021 | 18:42 ...

Pfizer-BioNTech - Find the Latest News, Views, Reviews, Comments, Analysis, Updates, Photos & Videos on Pfizer-BioNTech across Dubai, Abu Dhabi, UAE, Saudi Arabia, Gulf, GCC, Middle East & World.

Pfizer and BioNTech said they will share development costs and gross profits from future sales of the shingles vaccine. Pfizer will pay BioNTech $225 million in upfront payment, which includes a cash ...

Pfizer and BioNTech ramping up manufacturing capabilities to further increase production capacity in 2020/2021 NEW YORK, USA, and MAINZ, Germany – Pfizer Inc. (NYSE:PFE) and BioNTech SE (Nasdaq: BNTX) ...

Pfizer, BioNTech and Moderna are making combined profits of $65,000 every minute from their highly successful COVID-19 vaccines while the world's poorest countries remain largely unvaccinated, ...

BioNTech said on Tuesday that it and partner Pfizer would increase manufacturing capacity of their COVID-19 vaccine to 2.5 billion doses by the end of 2021, unveiling for the first time projected ...